scholarly article | Q13442814 |
P356 | DOI | 10.1017/ERM.2018.3 |
P698 | PubMed publication ID | 29747718 |
P2093 | author name string | Jigang Wang | |
Yin-Kwan Wong | |||
Fulong Liao | |||
P2860 | cites work | The Plasmodium falciparum Ca 2+ -ATPase PfATP6: insensitive to artemisinin, but a potential drug target | Q22061857 |
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum | Q22061870 | ||
Artemisinins target the SERCA of Plasmodium falciparum | Q22061877 | ||
A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer | Q22061945 | ||
Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes | Q23671265 | ||
A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered | Q23671266 | ||
The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption | Q44536650 | ||
Artesunate combinations for malaria | Q44786739 | ||
Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction | Q45110363 | ||
A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. | Q46365105 | ||
Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. | Q46420845 | ||
Dihydrotanshinone, a lipophilic component of Salvia miltiorrhiza (danshen), relaxes rat coronary artery by inhibition of calcium channels | Q46444472 | ||
Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin | Q46448577 | ||
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine | Q46656835 | ||
Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science | Q47248621 | ||
Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma | Q47597154 | ||
Western-medicine-validated anti-tumor agents and traditional Chinese medicine | Q47732460 | ||
The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates | Q47842376 | ||
Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. | Q48037496 | ||
Characterization of the Artemisinin Binding Site for Translationally Controlled Tumor Protein (TCTP) by Bioorthogonal Click Chemistry | Q48133209 | ||
Status and thoughts of Chinese patent medicines seeking approval in the US market | Q48540411 | ||
Excess hemoglobin digestion and the osmotic stability of Plasmodium falciparum-infected red blood cells. | Q52024420 | ||
Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats. | Q54325734 | ||
Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure | Q72145515 | ||
Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity | Q72405730 | ||
Differential SMN2 expression associated with SMA severity | Q77525869 | ||
Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore | Q77874093 | ||
Traditional Chinese medicine | Q79637865 | ||
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial | Q24630683 | ||
Efficacy of berberine in patients with type 2 diabetes mellitus | Q24645248 | ||
Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis | Q26765134 | ||
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. | Q26783902 | ||
Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis | Q26785588 | ||
The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus | Q28241824 | ||
Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides | Q28266857 | ||
Profiling of Multiple Targets of Artemisinin Activated by Hemin in Cancer Cell Proteome | Q28273065 | ||
The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin | Q28274190 | ||
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use | Q28282171 | ||
The quest for modernisation of traditional Chinese medicine | Q28292682 | ||
Cardiovascular effects of Danshen | Q28293119 | ||
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation | Q28367104 | ||
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia | Q28370464 | ||
Efficacy and safety of traditional chinese medicine for diabetes: a double-blind, randomised, controlled trial | Q28487001 | ||
Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver | Q28564768 | ||
Natural products as sources of new drugs over the 30 years from 1981 to 2010 | Q29616640 | ||
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein | Q29620737 | ||
Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture). | Q30248633 | ||
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity | Q30365127 | ||
Drug discovery and natural products: end of an era or an endless frontier? | Q30866998 | ||
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia | Q33409020 | ||
Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. | Q33551142 | ||
Biphasic effects of sodium danshensu on vessel function in isolated rat aorta | Q33557238 | ||
Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication | Q33650571 | ||
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer | Q34008520 | ||
The antimalarial drug artemisinin alkylates heme in infected mice | Q34015782 | ||
Arsenic trioxide - An old drug rediscovered | Q34054167 | ||
Heme as trigger and target for trioxane-containing antimalarial drugs. | Q34134820 | ||
Qinghaosu (artemisinin): an antimalarial drug from China | Q34193570 | ||
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine | Q34223139 | ||
Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy | Q34253726 | ||
Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis | Q34309558 | ||
Natural products: a continuing source of novel drug leads | Q34328933 | ||
The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis. | Q34331575 | ||
Arsenic trioxide, a therapeutic agent for APL. | Q34435492 | ||
Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission | Q34435558 | ||
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide | Q34478428 | ||
Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis | Q34511210 | ||
All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia | Q34546653 | ||
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia | Q34563645 | ||
Target identification for small bioactive molecules: finding the needle in the haystack | Q34589404 | ||
Arsenic trioxide: mechanisms of action | Q34638579 | ||
New developments in the chemistry and biology of the bioactive constituents of Tanshen | Q34652663 | ||
Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese. | Q34656398 | ||
Acute promyelocytic leukemia: from highly fatal to highly curable | Q34755208 | ||
Artemisinin: mechanisms of action, resistance and toxicity | Q34999485 | ||
Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection | Q35041476 | ||
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion | Q35105092 | ||
Application of berberine on treating type 2 diabetes mellitus | Q35226998 | ||
Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats | Q35398540 | ||
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension | Q35512345 | ||
Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus | Q35751965 | ||
Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies | Q35796683 | ||
Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility | Q35877249 | ||
Target identification of natural and traditional medicines with quantitative chemical proteomics approaches | Q35903397 | ||
Toward a scientific understanding of the effectiveness, material basis and prescription compatibility of a Chinese herbal formula Dan-hong injection | Q36341859 | ||
Modulating gut microbiota as an anti-diabetic mechanism of berberine. | Q36516516 | ||
The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice. | Q36803908 | ||
Molecular understanding and modern application of traditional medicines: triumphs and trials. | Q36828585 | ||
From traditional Chinese medicine to rational cancer therapy. | Q36888420 | ||
Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation | Q37069799 | ||
The Relationship between Traditional Chinese Medicine and Modern Medicine | Q37101065 | ||
Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. | Q37692436 | ||
Toxicity of the antimalarial artemisinin and its dervatives. | Q37693152 | ||
The molecular mechanism of action of artemisinin--the debate continues. | Q37718570 | ||
Berberine: a potential phytochemical with multispectrum therapeutic activities | Q37788220 | ||
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure | Q37802188 | ||
Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease | Q37999067 | ||
Artemisinins: pharmacological actions beyond anti-malarial | Q38169463 | ||
Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms | Q38442501 | ||
Effectiveness of Chinese herbal medicine for cancer palliative care: overview of systematic reviews with meta-analyses. | Q38669935 | ||
Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria | Q39188532 | ||
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria | Q39188623 | ||
Danshensu is the major marker for the antioxidant and vasorelaxation effects of Danshen (Salvia miltiorrhiza) water-extracts produced by different heat water-extractions | Q39268306 | ||
Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action. | Q39445570 | ||
Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. | Q39491810 | ||
Treatment of diabetes using traditional Chinese medicine: past, present and future | Q39562298 | ||
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression | Q39908313 | ||
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states | Q40250572 | ||
Progress in traditional Chinese medicine | Q40469875 | ||
Effects of berberine on glucose metabolism in vitro | Q40693802 | ||
Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase | Q40857729 | ||
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria | Q41918058 | ||
Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine. | Q41942403 | ||
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells | Q42545311 | ||
Blood's 70th anniversary: arsenic--from poison pill to magic bullet. | Q42910730 | ||
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. | Q42978007 | ||
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. | Q43830969 | ||
Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer | Q44348824 | ||
Molecular modes of action of artesunate in tumor cell lines. | Q44517624 | ||
P921 | main subject | traditional Chinese medicine | Q200253 |
P304 | page(s) | e4 | |
P577 | publication date | 2018-05-11 | |
P1433 | published in | Expert Reviews in Molecular Medicine | Q15755244 |
P1476 | title | What has traditional Chinese medicine delivered for modern medicine? | |
P478 | volume | 20 |
Search more.